TIDMSEED

RNS Number : 1977V

Seed Innovations Limited

30 November 2023

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

30 November 2023

SEED Innovations Limited

("SEED" or the "Company")

Transaction in Own Shares & TVR

SEED Innovations Ltd, the AIM-quoted company investment company providing shareholders with exposure to early-stage health, wellness and medical cannabis companies to which, in normal circumstances, they have limited access to, announces that it has purchased the following number of its shares of 1p each on the London Stock Exchange to be held in treasury (through Shard Capital Stockbrokers Limited ("Shard") acting as the Company's broker).

 
 Date of Purchase                          29 November 2023 
 Number of shares purchased (aggregated 
  volume):                                 1 00,000 
                                          ----------------- 
 Highest price paid per share              2. 3222 pence 
  (pence): 
                                          ----------------- 
 Lowest price paid per share               2.3222 pence 
  (pence): 
                                          ----------------- 
 Volume weighted average price             2.3222 pence 
  paid per share (pence): 
                                          ----------------- 
 

Following the purchase of these shares, the Company's issued ordinary share capital consists of 215,219,841 ordinary shares of which a total of 9,682,446 shares are held in treasury. The remaining 205,537,395 shares represent the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Shard on 29 November 2023 as part of the Programme as defined by the Company in the announcement on 29 September 2023.

Aggregate information:

 
 Venue    Volume-weighted average   Aggregated volume 
              price (pence per 
                   share) 
  AIMX            2.3222                 100,000 
         ------------------------  ------------------ 
 

Individual transactions:

 
Number of shares purchased  Transaction  Time of transaction  Venue 
                               price 
                             (pence per 
                               share) 
         100,000              2.3222          10.06.42        AIMX 
                            -----------  -------------------  ----- 
 

-Ends-

   For further information on the Company please visit:   www.seedinnovations.co or contact: 
 
 Ed McDermott        SEED Innovations         E: info@seedinnovations.co 
  Lance de Jersey     Ltd 
 James Biddle        Beaumont Cornish         T: (0)20 7628 3396 
  Roland Cornish      Limited, 
                      Nomad 
                    -----------------------  ------------------------------- 
 Isabella Pierre     Shard Capital Partners   T: (0)20 7186 9927 
  Damon Heath         LLP 
                      Broker 
                    -----------------------  ------------------------------- 
 Catherine Leftley   St Brides Partners       E: seed@stbridespartners.co.uk 
  Ana Ribeiro         Ltd, 
  Isabelle Morris     Financial PR 
                    -----------------------  ------------------------------- 
 

Notes

Seed Innovations Ltd

SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSFDISMSEDSEIF

(END) Dow Jones Newswires

November 30, 2023 02:00 ET (07:00 GMT)

Seed Innovations (LSE:SEED)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Seed Innovations.
Seed Innovations (LSE:SEED)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Seed Innovations.